BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 21738987)

  • 1. Leg ulcers and anticardiolipin antibodies.
    Skare TL
    An Bras Dermatol; 2011; 86(3):596-7. PubMed ID: 21738987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anticardiolipin antibodies in leg ulcers].
    Skare TL; Ribas CA; Malafaia O; Ribas Filho JM; Nassif PA; Nascimento MM; Fonseca VR
    Rev Col Bras Cir; 2009 Apr; 36(2):152-6. PubMed ID: 20076888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Platelet count and clinical profile of anticardiolipin positive leg ulcers].
    Skare TL; Ribas CA; Malafaia O; Ribas Filho JM; Nassif PA; Nascimento MM; Pachnicki JP
    Rev Col Bras Cir; 2009 Oct; 36(5):420-4. PubMed ID: 20069154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular dementia and anticardiolipin antibodies.
    de Godoy JM; de Godoy MR; Cipulo JP; Tognola VA
    Med Sci Monit; 2005 Sep; 11(9):CR430-3. PubMed ID: 16127362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.
    Merkel PA; Chang Y; Pierangeli SS; Convery K; Harris EN; Polisson RP
    Am J Med; 1996 Dec; 101(6):576-83. PubMed ID: 9003103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anticardiolipin antibodies and antibodies to beta(2)-glycoprotein I in patients with Wegener's granulomatosis.
    Lamprecht P; deGroot K; Schnabel A; Csernok E; Liedvogel B; Gross WL
    Rheumatology (Oxford); 2000 May; 39(5):568-70. PubMed ID: 10852995
    [No Abstract]   [Full Text] [Related]  

  • 7. Levels of anticardiolipin and anti-beta(2)-glycoprotein I antibodies in healthy newborn cord sera.
    Nicaise-Roland P; Aurousseau MH; Delaval A; Grootenboer-Mignot S; Hurtado M; Carbillon L; Fain O; Uzan M; Lachassine E; Boffa MC; Chollet-Martin S
    Thromb Haemost; 2008 Jun; 99(6):1124-6. PubMed ID: 18521522
    [No Abstract]   [Full Text] [Related]  

  • 8. Association between anticardiolipin antibodies and mortality in patients with peripheral arterial disease.
    Puisieux F; de Groote P; Masy E; Di Pompeo C; Millaire A; Bouillanne O; Jude B; Dewailly P; Ducloux G
    Am J Med; 2000 Dec; 109(8):635-41. PubMed ID: 11099683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic neutrophils and anticardiolipin antibodies.
    Courtney PA; Crockard AD; McMillan SA; Cairns AP; Bell AL
    Clin Exp Rheumatol; 2001; 19(4):476. PubMed ID: 11491511
    [No Abstract]   [Full Text] [Related]  

  • 10. Serum anti-beta2-glycoprotein-I and anticardiolipin antibodies during thrombosis in systemic lupus erythematosus patients.
    Gómez-Pacheco L; Villa AR; Drenkard C; Cabiedes J; Cabral AR; Alarcón-Segovia D
    Am J Med; 1999 Apr; 106(4):417-23. PubMed ID: 10225244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticardiolipin antibodies and ulcerations of the leg.
    Barbaud AM; Gobert B; Reichert S; Schmutz JL; Bene MC; Weber M; Faure GC
    J Am Acad Dermatol; 1994 Oct; 31(4):670-1. PubMed ID: 8089297
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticardiolipin antibodies and osteonecrosis of the femoral head.
    Korompilias AV; Gilkeson GS; Ortel TL; Seaber AV; Urbaniak JR
    Clin Orthop Relat Res; 1997 Dec; (345):174-80. PubMed ID: 9418637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of anticardiolipin antibodies in patients with systemic sclerosis.
    Picillo U; Migliaresi S; Marcialis MR; Ferruzzi AM; Tirri G
    Autoimmunity; 1995; 20(1):1-7. PubMed ID: 7578856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticardiolipin and antinuclear antibodies in the adult healthy Omani individuals.
    Al Jabri AA; Al Buloshi MS
    Saudi Med J; 2004 Mar; 25(3):313-7. PubMed ID: 15048168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of anticardiolipin antibodies in subacute cutaneous lupus erythematosus.
    Fonseca E; Alvarez R; González MR; Pascual D
    Lupus; 1992 Aug; 1(4):265-8. PubMed ID: 1301991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activated protein C resistance and cardiolipin antibodies in leg ulcers].
    Maréchal V; De Maistre E; Barbaud A; Albuisson E; Lecompte T; Gobert B; Bene M; Faure G; Schmutz J
    Ann Dermatol Venereol; 2000; 127(6-7):585-9. PubMed ID: 10930855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticardiolipin antibodies in rheumatoid arthritis: their relation to rheumatoid nodules and cutaneous vascular manifestations.
    Wolf P; Gretler J; Aglas F; Auer-Grumbach P; Rainer F
    Br J Dermatol; 1994 Jul; 131(1):48-51. PubMed ID: 8043421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent problems with standardization of immunoassays for anti-cardiolipin antibodies.
    Fontaine M; Homburger HA; Nichols WL
    Thromb Haemost; 2001 Oct; 86(4):1123-4. PubMed ID: 11686339
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of beta 2-glycoprotein I-dependent anticardiolipin antibodies in the reproductive autoimmune failure syndrome: correlation with conventional antiphospholipid antibody detection systems.
    Aoki K; Dudkiewicz AB; Matsuura E; Novotny M; Kaberlein G; Gleicher N
    Am J Obstet Gynecol; 1995 Mar; 172(3):926-31. PubMed ID: 7892887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticardiolipin autoantibodies in serum samples and cryoglobulins of patients with chronic hepatitis C infection.
    Sthoeger ZM; Fogel M; Smirov A; Ergas D; Lurie Y; Bass DD; Geltner D; Malnick SD
    Ann Rheum Dis; 2000 Jun; 59(6):483-6. PubMed ID: 10834867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.